These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 2260966)

  • 61. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element.
    Verrijdt G; Schoenmakers E; Alen P; Haelens A; Peeters B; Rombauts W; Claessens F
    Mol Endocrinol; 1999 Sep; 13(9):1558-70. PubMed ID: 10478846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo regulation of hTERT expression and telomerase activity by androgen.
    Guo C; Armbruster BN; Price DT; Counter CM
    J Urol; 2003 Aug; 170(2 Pt 1):615-8. PubMed ID: 12853842
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes.
    Gao N; Zhang J; Rao MA; Case TC; Mirosevich J; Wang Y; Jin R; Gupta A; Rennie PS; Matusik RJ
    Mol Endocrinol; 2003 Aug; 17(8):1484-507. PubMed ID: 12750453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.
    Nesslinger NJ; Shi XB; deVere White RW
    Cancer Res; 2003 May; 63(9):2228-33. PubMed ID: 12727844
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.
    Olea N; Sakabe K; Soto AM; Sonnenschein C
    Endocrinology; 1990 Mar; 126(3):1457-63. PubMed ID: 2307113
    [TBL] [Abstract][Full Text] [Related]  

  • 67. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
    Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
    Grant ES; Batchelor KW; Habib FK
    Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanism of androgen action: recent observations on the domain structure of androgen receptors and the induction of EGF-receptors by androgens in prostate tumor cells.
    Mulder E; van Loon D; de Boer W; Schuurmans AL; Bolt J; Voorhorst MM; Kuiper GG; Brinkmann AO
    J Steroid Biochem; 1989 Jan; 32(1B):151-6. PubMed ID: 2643738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mechanisms of androgen receptor activation and function.
    Brinkmann AO; Blok LJ; de Ruiter PE; Doesburg P; Steketee K; Berrevoets CA; Trapman J
    J Steroid Biochem Mol Biol; 1999; 69(1-6):307-13. PubMed ID: 10419007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis of C-6 fluoroandrogens: evaluation of ligands for tumor receptor imaging.
    Choe YS; Katzenellenbogen JA
    Steroids; 1995 May; 60(5):414-22. PubMed ID: 7570716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Steroid metabolism and binding in relation to prostatic cell growth and differentiation in vitro.
    Chevalier S; Turcotte G; McKercher G; Boulanger P; Chapdelaine A
    Ann N Y Acad Sci; 1990; 595():173-83. PubMed ID: 2375603
    [No Abstract]   [Full Text] [Related]  

  • 73. Androgen receptor variants: another twist in the plot.
    Macoska JA
    Oncotarget; 2017 Mar; 8(10):16100. PubMed ID: 28184022
    [No Abstract]   [Full Text] [Related]  

  • 74. Predicting the Activation of the Androgen Receptor by Mixtures of Ligands Using Generalized Concentration Addition.
    Schlezinger JJ; Heiger-Bernays W; Webster TF
    Toxicol Sci; 2020 Oct; 177(2):466-475. PubMed ID: 32726424
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic analysis of androgen receptors in development and disease.
    Brinkmann AO; Trapman J
    Adv Pharmacol; 2000; 47():317-41. PubMed ID: 10582090
    [No Abstract]   [Full Text] [Related]  

  • 76. Androgen-dependent immune modulation in parasitic infection.
    Sellau J; Groneberg M; Lotter H
    Semin Immunopathol; 2019 Mar; 41(2):213-224. PubMed ID: 30353258
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Androgen regulation of lipogenesis.
    Swinnen JV; Heemers H; Heyns W; Verhoeven G
    Adv Exp Med Biol; 2002; 506(Pt A):379-87. PubMed ID: 12613937
    [No Abstract]   [Full Text] [Related]  

  • 78. Integrative clinical genomics of advanced prostate cancer.
    Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
    Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509.
    Joseph JD; Lu N; Qian J; Sensintaffar J; Shao G; Brigham D; Moon M; Maneval EC; Chen I; Darimont B; Hager JH
    Cancer Discov; 2013 Sep; 3(9):1020-9. PubMed ID: 23779130
    [TBL] [Abstract][Full Text] [Related]  

  • 80. LNCaP model of human prostatic carcinoma.
    Horoszewicz JS; Leong SS; Kawinski E; Karr JP; Rosenthal H; Chu TM; Mirand EA; Murphy GP
    Cancer Res; 1983 Apr; 43(4):1809-18. PubMed ID: 6831420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.